Ida Vind
Clinical Associate Professor
Department of Clinical Medicine
Blegdamsvej 3
2200 København N.
Member of:
Internal Medicine: Gastroenterology and Hepatology
1 - 3 out of 3Page size: 25
- 2021
- Published
Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn's disease - a real-world two-center cohort study
Attauabi, M., Vind, Ida, Pedersen, G., Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2021, In: European journal of gastroenterology & hepatology. 33, 15, p. 709-718Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Cohort Studies
Lo, B., Zhao, M., Vind, Ida & Burisch, J., 2021, In: Clinical Gastroenterology and Hepatology. 19, 6, p. 1117-1138.e19 41 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study
for the NOVA Study Group, F. T. N. S. G., 2021, In: Alimentary Pharmacology and Therapeutics. 54, 10, p. 1320-1329 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 21472222
Most downloads
-
70
downloads
Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis
Research output: Contribution to journal › Journal article › Research › peer-review
Published